Phospholipase A2 Receptor 1 Epitope Spreading at Baseline Predicts Reduced Likelihood of Remission of Membranous Nephropathy.
Seitz-Polski, Barbara
Phospholipase A2 Receptor 1 Epitope Spreading at Baseline Predicts Reduced Likelihood of Remission of Membranous Nephropathy. [electronic resource] - Journal of the American Society of Nephrology : JASN 02 2018 - 401-408 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1533-3450
10.1681/ASN.2017070734 doi
Adult
Autoantibodies--blood
Autoantigens--immunology
Epitopes--drug effects
Female
Glomerulonephritis, Membranous--blood
Humans
Immunologic Factors--therapeutic use
Male
Middle Aged
Predictive Value of Tests
Prospective Studies
Receptors, Phospholipase A2--immunology
Remission Induction
Rituximab--therapeutic use
Phospholipase A2 Receptor 1 Epitope Spreading at Baseline Predicts Reduced Likelihood of Remission of Membranous Nephropathy. [electronic resource] - Journal of the American Society of Nephrology : JASN 02 2018 - 401-408 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1533-3450
10.1681/ASN.2017070734 doi
Adult
Autoantibodies--blood
Autoantigens--immunology
Epitopes--drug effects
Female
Glomerulonephritis, Membranous--blood
Humans
Immunologic Factors--therapeutic use
Male
Middle Aged
Predictive Value of Tests
Prospective Studies
Receptors, Phospholipase A2--immunology
Remission Induction
Rituximab--therapeutic use